Grow Opportunity

News Business International Psychedelics
Lucy Scientific Discovery partners with High Times to develop and distribute a new line of psychoactive products

March 23, 2023  By Grow Opportunity Staff

(Globe Newswire) Vancouver — Lucy Scientific Discovery Inc., a leading NASDAQ-listed psychedelic drug manufacturer, has launched of a new line of unscheduled psychoactive compounds that will be available for sale throughout the United States, and where permitted throughout the rest of the world.

The first line in the new family of brands contains Amanita Muscaria mushrooms, a psychoactive adaptogen. The product leverages the compounds of these mushrooms, and a proprietary blend of other natural functional ingredients, to create a transformative experience for consumers worldwide. This product line is named ‘Mindful by Lucy.’

Lucy Scientific will produce Mindful with High Times, through a strategic partnership with Hightimes Holding Corp., the parent company of High Times®, the most well-known brand in cannabis. This collaboration aims to distribute and market the products initially through High Times’ websites and social channels which reach over 10 million people across their owned and operated properties and social media accounts.

With a product launch targeted for Q2 2023, this new line is well-positioned to capitalize on the growing market for psychoactive alternatives, which Forbes predicts will double to over $5 billion in gross sales by 2025.


Lucy and High Times entered into a strategic investment agreement in January whereby Lucy received $2.5 million in advertising credits that will help launch the new brand into market through High Times channels and experiential events.

“As awareness and acceptance of alternative treatments for various conditions, such as PTSD, anxiety disorders, and depression, continue to grow, adaptogens are emerging as a leading therapeutic remedy. This partnership between Lucy and High Times will enable the two companies to expand the reach of Lucy’s products and promote the potential health benefits to a broader audience.” — Chris McElvany, CEO, Lucy Scientific Discovery Inc.

Print this page


Stories continue below